Your browser doesn't support javascript.
loading
Interleukin-6 Family of Cytokines in Cancers.
Zaporowska-Stachowiak, Iwona; Springer, Michal; Stachowiak, Katarzyna; Oduah, Mary; Sopata, Maciej; Wieczorowska-Tobis, Katarzyna; Bryl, Wieslaw.
Afiliação
  • Zaporowska-Stachowiak I; Department and Clinic of Palliative Medicine, Poznan University of Medical Sciences, Poznan, Poland.
  • Springer M; Palliative Medicine In-Patient Unit, University Hospital of Lord's Transfiguration, Poznan University of Medical Sciences, Poznan, Poland.
  • Stachowiak K; Department of Internal Diseases, Metabolic Disorders and Arterial Hypertension, Poznan University of Medical Sciences, Poznan, Poland.
  • Oduah M; Institute of Applied Linguistics, University of Warsaw, Warsaw, Poland.
  • Sopata M; English Students' Research Association, Poznan University of Medical Sciences, Poznan, Poland.
  • Wieczorowska-Tobis K; Department and Clinic of Palliative Medicine, Poznan University of Medical Sciences, Poznan, Poland.
  • Bryl W; Palliative Medicine In-Patient Unit, University Hospital of Lord's Transfiguration, Poznan University of Medical Sciences, Poznan, Poland.
J Interferon Cytokine Res ; 44(2): 45-59, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38232478
ABSTRACT
Nine soluble ligands [interleukin-6 (IL-6), interleukin-11 (IL-11), leukemia inhibitory factor (LIF), oncostatin M (OSM), ciliary neurotrophic factor (CNTF), cardiotrophin-1 (CT-1), cardiotrophin-like cytokine, interleukin-27 (IL-27), and interleukin-31] share the ubiquitously expressed transmembrane protein-glycoprotein-130 beta-subunit (gp130) and thus form IL-6 family cytokines. Proteins that may be important for cancerogenesis, CT-1, IL-11, IL-27, LIF, OSM, and CNTF, belong to the superfamily of IL-6. Cytokines such as IL-6, IL-11, and IL-27 are better investigated in comparison with other members of the same family of cytokines, eg, CT-1. Gp130 is one of the main receptors through which these cytokines exert their effects. The clinical implication of understanding the pathways of these cytokines in oncology is that targeted therapy to inhibit or potentiate cytokine activity may lead to remission in some cases.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-27 / Neoplasias Limite: Humans Idioma: En Revista: J Interferon Cytokine Res Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-27 / Neoplasias Limite: Humans Idioma: En Revista: J Interferon Cytokine Res Ano de publicação: 2024 Tipo de documento: Article